Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 27, 2012

Primary Completion Date

June 24, 2015

Study Completion Date

March 27, 2019

Conditions
Liver Disease
Interventions
BIOLOGICAL

Fresh Frozen Plasma

An INR dose-response curve with associated transfusion algorithm was generated for plasma in bleeding patients with chronic liver disease. In the intervention arm we will determine the plasma transfusion dose using the algorithm dosing table based on the pre-transfusion INR and the clinician chosen INR target. In the usual care group the dosing will be determined by the clinician.

DIAGNOSTIC_TEST

Pre-Transfusion International Normalized Ratio (INR)

INR result prior to Fresh Frozen Plasma (FFP) transfusion determined by clinical lab testing performed within 6 hours to 1 day before transfusion start time.

DIAGNOSTIC_TEST

Post-Transfusion International Normalized Ratio (INR)

INR result after Fresh Frozen Plasma (FFP) transfusion completed, determined by clinical lab testing performed within 1 hour after transfusion completed.

Trial Locations (1)

80045

University of Colorado Hospital, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02366845 - Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease | Biotech Hunter | Biotech Hunter